[{"indications": "Indications\u00a0see preparations; malignant disease (section 8.1.5)", "name": "TRETINOIN - TOPICAL RETINOIDS AND RELATED PREPARATIONS FOR ACNE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.6 Acne and rosacea", "13.6.1 Topical preparations for acne", "Topical retinoids and related preparations for acne", "TRETINOIN"], "cautions": "Cautions\u00a0\n(From Topical retinoids and related preparations for acne: British National Formulary)\nTopical retinoids and related preparations for acne", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106179.htm", "doses": ["See preparations"], "pregnancy": "Pregnancy\u00a0\n(From Topical retinoids and related preparations for acne: British National Formulary)\nPregnancy\u00a0Topical retinoids are contra-indicated in pregnancy; women of child-bearing age must use effective contraception (oral progestogen-only contraceptives not considered effective)."}, {"indications": "Indications\u00a0\n(From Tretinoin: British National Formulary)\nTretinoin; acne (%s\n(From 13.6.1 Topical preparations for acne: British National Formulary)\n13.6.1 Topical preparations for acne); photodamage (%s\n(From 13.8.1 Sunscreen preparations: British National Formulary)\n13.8.1 Sunscreen preparations)", "name": "TRETINOIN - TRETINOIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.5 Other antineoplastic drugs", "Tretinoin"], "cautions": "Cautions\u00a0exclude pregnancy before starting treatment; monitor haematological and coagulation profile, liver\r\nfunction, serum calcium and plasma lipids before and during treatment; increased risk of thromboembolism during first month\r\nof treatment; interactions: Appendix\r\n1 (retinoids)", "side-effects": "Side-effects\u00a0retinoic acid syndrome (fever, dyspnoea, acute\r\nrespiratory distress, pulmonary infiltrates, pleural effusion, hyperleucocytosis,\r\nhypotension, oedema, weight gain, hepatic, renal and multi-organ failure)\r\nrequires immediate treatment\u2014consult product literature; gastro-intestinal\r\ndisturbances, pancreatitis; arrhythmias, flushing, oedema; headache,\r\nbenign intracranial hypertension (mainly in children\u2014consider dose\r\nreduction if intractable headache in children), shivering, dizziness,\r\nconfusion, anxiety, depression, insomnia, paraesthesia, visual and\r\nhearing disturbances; raised liver enzymes, serum creatinine and lipids;\r\nbone and chest pain, alopecia, erythema, rash, pruritus, sweating,\r\ndry skin and mucous membranes, cheilitis; thromboembolism,\r\nhypercalcaemia, and genital ulceration reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/65167.htm", "doses": ["adult and child 45\u00a0mg/m2 daily in 2 divided doses,\r\nmax. duration of treatment 90 days (consult product literature for\r\ndetails of concomitant chemotherapy)"], "pregnancy": "Pregnancy\u00a0teratogenic; effective contraception must be used\r\nfor at least 1 month before oral treatment, during treatment and for\r\nat least 1 month after stopping (oral progestogen-only contraceptives\r\nnot considered effective)"}, {"indications": "Indications\u00a0see preparations; malignant disease (section 8.1.5)", "name": "TRETINOIN With antibacterial", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.6 Acne and rosacea", "13.6.1 Topical preparations for acne", "Topical retinoids and related preparations for acne", "TRETINOIN", "With antibacterial"], "cautions": "Cautions\u00a0\n(From Topical retinoids and related preparations for acne: British National Formulary)\nTopical retinoids and related preparations for acne", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106180.htm", "doses": ["See preparations", "Name[Aknemycin\u00ae Plus (Almirall) ] Solution, tretinoin 0.025%, erythromycin 4% in an alcoholic basis,\r\nnet price 25\u00a0mL = \u00a37.05. \r\n    Label:\r\n    11Excipients  none as listed in section 13.1.3Dose\u00a0acne, apply thinly 1\u20132 times daily"], "pregnancy": "Pregnancy\u00a0\n(From Topical retinoids and related preparations for acne: British National Formulary)\nPregnancy\u00a0Topical retinoids are contra-indicated in pregnancy; women of child-bearing age must use effective contraception (oral progestogen-only contraceptives not considered effective)."}, {"indications": "Indications\u00a0\n(From Tretinoin: British National Formulary)\nTretinoin; acne (%s\n(From 13.6.1 Topical preparations for acne: British National Formulary)\n13.6.1 Topical preparations for acne); photodamage (%s\n(From 13.8.1 Sunscreen preparations: British National Formulary)\n13.8.1 Sunscreen preparations)", "name": "TRETINOIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.5 Other antineoplastic drugs", "Tretinoin"], "cautions": "Cautions\u00a0exclude pregnancy before starting treatment; monitor haematological and coagulation profile, liver\r\nfunction, serum calcium and plasma lipids before and during treatment; increased risk of thromboembolism during first month\r\nof treatment; interactions: Appendix\r\n1 (retinoids)", "side-effects": "Side-effects\u00a0retinoic acid syndrome (fever, dyspnoea, acute\r\nrespiratory distress, pulmonary infiltrates, pleural effusion, hyperleucocytosis,\r\nhypotension, oedema, weight gain, hepatic, renal and multi-organ failure)\r\nrequires immediate treatment\u2014consult product literature; gastro-intestinal\r\ndisturbances, pancreatitis; arrhythmias, flushing, oedema; headache,\r\nbenign intracranial hypertension (mainly in children\u2014consider dose\r\nreduction if intractable headache in children), shivering, dizziness,\r\nconfusion, anxiety, depression, insomnia, paraesthesia, visual and\r\nhearing disturbances; raised liver enzymes, serum creatinine and lipids;\r\nbone and chest pain, alopecia, erythema, rash, pruritus, sweating,\r\ndry skin and mucous membranes, cheilitis; thromboembolism,\r\nhypercalcaemia, and genital ulceration reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/65167.htm", "doses": ["adult and child 45\u00a0mg/m2 daily in 2 divided doses,\r\nmax. duration of treatment 90 days (consult product literature for\r\ndetails of concomitant chemotherapy)"], "pregnancy": "Pregnancy\u00a0teratogenic; effective contraception must be used\r\nfor at least 1 month before oral treatment, during treatment and for\r\nat least 1 month after stopping (oral progestogen-only contraceptives\r\nnot considered effective)"}]